Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)

DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)

pharmaceutical raw materials
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) structure

DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) 

structure
  • CAS No:

    204318-14-9

  • Formula:

    C65H92N14O18S2

  • Chemical Name:

    DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Edotreotide is a chelated octreotide derivative with somatostatin activity. Edotreotide is produced by substituting tyrosine for phenylalanine at the 3 position of octreotide and chelated via dodecanetetraacetic acid (DOTA). Like octreotide, this edotreotide binds to somatostatin receptors (SSTRs), especially type 2, present on the cell membrane of many types of neuroendocrine tumors. When labeled with nuclides, edotreotide conjugates could result in tissue specific cytotoxicity.

DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) Basic Attributes

1421.64000

1420.61554449 g/mol

U194AS08HZ

C2616

V09IX

Characteristics

530.99000

-0.19830

1.46g/cm3

1723.7ºC at 760 mmHg

996.2ºC

1.684

0mmHg at 25°C

Drug Information

This medicinal product is for diagnostic use only.After radiolabelling with gallium (68Ga) chloride solution, the solution of gallium (68Ga) edotreotide obtained is indicated for Positron Emission Tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected well-differentiated gastro-enteropancreatic neuroendocrine tumours (GEP-NET) for localizing primary tumours and their metastases.

Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)

(DOTA(0)-Phe(1)-Tyr(3))octreotide

DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) Use and Manufacturing

Human drugs -> Orphan -> SomaKit TOC -> EMA Drug Category|Diagnostic radiopharmaceuticals -> Human pharmacotherapeutic group

Computed Properties

Molecular Weight:1421.6
XLogP3:-7.2
Hydrogen Bond Donor Count:17
Hydrogen Bond Acceptor Count:25
Rotatable Bond Count:26
Exact Mass:1420.61554449
Monoisotopic Mass:1420.61554449
Topological Polar Surface Area:531
Heavy Atom Count:99
Complexity:2620
Defined Atom Stereocenter Count:10
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.